Search

Search for
Advanced filters
Keyword(s)	Delete

Additional Search Options (click to show) Additional Search Options (click to hide)

Search categories
Authors
Title
Abstract
Full Text
Search in PDF
Supplementary File(s)
Publication Date
From
Until
Index terms
Discipline(s)
Type (method/approach)
Coverage
All index term fields

Issue

Title

Authors

Vol 13, No 5 (2013)

Type II Kinase Inhibitors: An Opportunity in Cancer for Rational Design

Blanc J., Geney R., Menet C.

(Eng)

Vol 15, No 2 (2015)

Recent Developments on Thiourea Based Anticancer Chemotherapeutics

Kumar V., Chimni S.

(Eng)

Vol 12, No 4 (2012)

Recent Developments of Small Molecule EGFR Inhibitors Based on the Quinazoline Core Scaffolds

Liu Y., Zhang C., Liu Z.

(Eng)

Vol 10, No 6 (2010)

Therapeutic Exploitation of Apoptosis and Autophagy for Glioblastoma

Kogel D., Fulda S., Mittelbronn M.

(Eng)

Vol 14, No 7 (2014)

EGFRIndb: Epidermal Growth Factor Receptor Inhibitor Database

Yadav I., Singh H., Khan M., Chaudhury A., Raghava G., Agarwal S.

(Eng)

Vol 12, No 4 (2012)

Downregulation of Hypoxia-related Responses by Novel Antitumor Histone Deacetylase Inhibitors in MDAMB231 Breast Cancer Cells

Naldini A., Filippi I., Cini E., Rodriquez M., Carraro F., Taddei M.

(Eng)

Vol 16, No 10 (2016)

Natural Product-Derived Spirooxindole Fragments Serve as Privileged Substructures for Discovery of New Anticancer Agents

Yu B., Zheng Y., Shi X., Qi P., Liu H.

(Eng)

Vol 12, No 7 (2012)

Inhibiting Matrix Metalloproteinases, an Old Story with New Potentials for Cancer Treatment

Stellas D., Patsavoudi E.

(Eng)

Vol 15, No 4 (2015)

New Treatments for Cutaneous Metastatic Melanoma: MAPK Pathway-Targeted and Immune Based Therapies

Ranchon , Boespflug , Rioufol , Schwiertz , Thomas , Dalle

(Eng)

Vol 12, No 6 (2012)

Current and Emerging Strategies in Bladder Cancer

Carradori S., Cristini C., Secci D., Gulia C., Gentile V., Battista Di Pierro G.

(Eng)

Vol 14, No 5 (2014)

Physiological Modulation Approaches to Improve Cancer Chemotherapy : A Review

Kumar R., Kaur M., Silakari O.

(Eng)

Vol 10, No 9 (2010)

Potential New Agents for Chronic Lymphocytic Leukemia Treatment

Rogalinska M., M. Kilianska Z.

(Eng)

Vol 16, No 10 (2016)

Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site

Wu X., Wang Q., Li W.

(Eng)

Vol 15, No 3 (2015)

Immune Checkpoint Inhibitors for Non-small-cell Lung Cancer: Does that Represent a ‘New Frontier’?

Pilotto S., Kinspergher S., Peretti U., Calio A., Carbognin L., Ferrara R., Brunelli M., Chilosi M., Tortora G., Bria E.

(Eng)

Vol 14, No 1 (2014)

Genetics, Structure, Function, Mode of Actions and Role in Cancer Development of CYP17

Sushko T., Gilep A., Usanov S.

(Eng)

Vol 12, No 9 (2012)

Rational Drug Design for Identifying Novel Multi-target Inhibitors for Hepatocellular Carcinoma

Temirak A., Abdulla M., Elhefnawi M.

(Eng)

Vol 11, No 8 (2011)

Erlotinib in Glioblastoma - Lost in Translation?

Karpel-Massler G., Andrew Westhoff M., E. Kast R., Rainer Wirtz C., Halatsch M.

(Eng)

Vol 10, No 8 (2010)

Mechanisms of Drug Resistance to Vascular Endothelial Growth Factor (VEGF) Inhibitors

Tavakoli J., B. Aragon-Ching J.

(Eng)

Vol 25, No 18 (2025)

Design and Synthesis of 2-substituted [1,2,4]Triazolo[1,5-a]pyrimidines Tethered with Umbelliferone as Selective Carbonic Anhydrase IX and XII Inhibitors

Romagnoli R., Romagnoli E., Brancale A., Supuran C., Nocentini A., Manfreda L., Zanolli A., Bortolozzi R., Viola G.

(Eng)

Vol 14, No 1 (2014)

Nonsteroidal Aromatase Inhibitors for the Treatment of Breast Cancer: An Update

Gobbi S., Rampa A., Belluti F., Bisi A.

(Eng)

Vol 14, No 1 (2014)

Nonsteroidal Aromatase Inhibitors for the Treatment of Breast Cancer: An Update

Gobbi S., Rampa A., Belluti F., Bisi A.

(Eng)

Vol 12, No 8 (2012)

Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization

Shen M., Hang Chan T., Ping Dou Q.

(Eng)

Vol 11, No 7 (2011)

Clinical Importance and Potential Use of Small Molecule Inhibitors of Focal Adhesion Kinase

Schultze A., Fiedler W.

(Eng)

Vol 10, No 7 (2010)

Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP Inhibitors

J. Chalmers A.

(Eng)

Vol 25, No 14 (2025)

Design, Synthesis, and Molecular Docking Studies of Indolo[3,2-c]Quinolines as Topoisomerase Inhibitors

Badr M., Elmongy E., Sayed I., Moemen Y., Khalil A., Elkhateeb D., Binsuwaidan R., Ali H.

(Eng)

Vol 24, No 4 (2024)

Design and Pharmacophore Study of Triazole Analogues as Aromatase Inhibitors

Banjare L.

(Eng)

Vol 16, No 1 (2016)

Therapeutic Potential of Targeting PAK Signaling

Senapedis W., Crochiere M., Baloglu E., Landesman Y.

(Eng)

Vol 14, No 9 (2014)

New Potent and Selective Inhibitor of Pim-1/3 Protein Kinases Sensitizes Human Colon Carcinoma Cells to Doxorubicin

Moreau P., Dezhenkova L., Anizon F., Nauton L., Thery V., Liang S., Kaluzhny D., Shtil A.

(Eng)

Vol 13, No 8 (2013)

Celecoxib Inhibits Helicobacter pylori-induced Invasion of Gastric Cancer Cells Through an Adenine Nucleotide Translocator-Dependent Mechanism

Lan C., Yang L., Fan L., Zhang Y., Wang J., Guo G., Wan S., Yang S., Wang R., Fang D.

(Eng)

Vol 12, No 7 (2012)

Design of N-substituted Amino Caproic Hydroxamic Acid Histone Deacetylase Inhibitors Reveal an Essential Role for Cap Atomic Composition

M. Brunel J., Salmi-Smail C., Restouin A., Prebet T., Vey N., Collette Y.

(Eng)

Vol 12, No 4 (2012)

Alteration of Ceramide 1-O-Functionalization as a Promising Approach for Cancer Therapy

Ballereau S., Levade T., Genisson Y., Andrieu-Abadie N.

(Eng)

Vol 11, No 6 (2011)

Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma

Wen Chong L., Anh Tuan Luu D., Tzen Jong C., Wei Ling Lam I., Huynh H., Wei Jie Ong R., Yi Qing Li P., Shean Lee S., Yang S.

(Eng)

Vol 10, No 6 (2010)

Exploiting Cyclooxygenase-(in)Dependent Properties of COX-2 Inhibitors for Malignant Glioma Therapy

H. Schonthal A.

(Eng)

Vol 25, No 1 (2025)

Evaluation of Novel Diaza Cage Compounds as MRP Modulators in Cancer Cells

Döring H., Kreutzer D., von Veh J., Ritter C., Hilgeroth A.

(Eng)

Vol 24, No 2 (2024)

Chalcones as Potential Cyclooxygenase-2 Inhibitors: A Review

Mahboubi-Rabbani M., Zarei R., Baradaran M., Bayanati M., Zarghi A.

(Eng)

Vol 15, No 8 (2015)

Recent Advancement in Discovery and Development of Natural Product Combretastatin-inspired Anticancer Agents

O. Patil P., G. Patil A., A. Rane R., C. Patil P., K. Deshmukh P., B. Bari S., A. Patil D., S. Naphade S.

(Eng)

Vol 14, No 9 (2014)

Histone Deacetylase Inhibitors and Colorectal Cancer: what is new?

Tampakis A., Tampaki E., Nebiker C., Kouraklis G.

(Eng)

Vol 12, No 7 (2012)

Differential Expressions of Matrix Metalloproteinases, A Disintegrin and Metalloproteinases, and a Disintegrin and Metalloproteinases with Thrombospondin Motifs and their Endogenous Inhibitors Among Histologic Subtypes of Lung Cancers

Hida Y., Hamada J.

(Eng)

Vol 12, No 4 (2012)

Sphingolipid Modulation: A Strategy for Cancer Therapy

Delgado A., Fabrias G., Bedia C., Casas J., Abad J.L.

(Eng)

Vol 11, No 3 (2011)

Astemizole: an Old Anti-histamine as a New Promising Anti-cancer Drug

Garcia-Quiroz J., Camacho J.

(Eng)

Vol 25, No 10 (2025)

Bioactive Products Targeting C-Met As Potential Antitumour Drugs

Zhao L., Qian C., Ma X., Wang X.

(Eng)

Vol 24, No 16 (2024)

Natural Compounds as Protease Inhibitors in Therapeutic Focus on Cancer Therapy

Kakali B.

(Eng)

Vol 15, No 8 (2015)

Anti-cancer Glycosidase Inhibitors from Natural Products: A Computational and Molecular Modelling Perspective

Singh A., Mhlongo N., Soliman M.

(Eng)

Vol 14, No 8 (2014)

Episensitization: Therapeutic Tumor Resensitization by Epigenetic Agents: A Review and Reassessment

Oronsky B., Oronsky N., Knox S., Fanger G., Scicinski J.

(Eng)

Vol 13, No 3 (2013)

NADPH Oxidases NOXs and DUOXs as Putative Targets for Cancer Therapy

Weyemi U., E. Redon C., R. Parekh P., Dupuy C., M. Bonner W.

(Eng)

Vol 12, No 3 (2012)

Selective Histone Deacetylase Inhibitors

Pan H., Cao J., Xu W.

(Eng)

Vol 11, No 10 (2011)

TEM8 Targeted Cancer Therapy

E. Frankel A., Carter C., Kuo S., Woo J., Mauldin J., Liu J.

(Eng)

Vol 10, No 3 (2010)

Recent Advances and Future Directions in the Management of Metastatic Renal Cell Carcinoma

Ansari J., Glaholm J., McMenemin R., James N., Hussain S.

(Eng)

Vol 25, No 10 (2025)

Advances in VEGFR Inhibitors: A Comprehensive Review of Novel Anticancer Agents

Jha S., Gupta S., Rani S., Arora P., Choudhary N., Kumar S.

(Eng)

Vol 24, No 15 (2024)

The Importance of Structural Water in HDAC8 for Correct Binding Pose Applied for Drug Design of Anticancer Molecules

Morales-Herrejón G., Mendoza-Figueroa H., Martínez-Archundía M., Correa-Basurto J.

(Eng)

Vol 15, No 5 (2015)

Recent Trends of Chalcones Potentialities as Antiproliferative and Antiresistance Agents

Winter E., Locatelli C., Pietro A., Creczynski-Pasa T.

(Eng)

Vol 13, No 3 (2013)

Treatment Directed to Signalling Molecules in Patients with Advanced Differentiated Thyroid Cancer

M.G. Saez J.

(Eng)

Vol 12, No 6 (2012)

Triple-negative Breast Cancer and Poly(ADP-ribose) Polymerase Inhibitors

Park Y., Moriyama A., Kitahara T., Yoshida Y., Urita T., Kato R.

(Eng)

Vol 12, No 3 (2012)

Molecular Probing and Imaging of Histone Deacetylase Inhibitors in Cancer Treatment

Jiaguo H., Zhiguo L., Wenbin Z.

(Eng)

Vol 11, No 1 (2011)

Molecular Field Analysis (MFA) and Other QSAR Techniques in Development of Phosphatase Inhibitors

C. Nair P.

(Eng)

Vol 10, No 10 (2010)

Evolving Therapies and FAK Inhibitors for the Treatment of Cancer

Bullard Dunn K., Heffler M., M. Golubovskaya V.

(Eng)

Vol 23, No 11 (2023)

Development of Novel Indole-3-sulfonamide-heteroaryl Hybrids as Carbonic Anhydrase Inhibitors: Design, Synthesis and in-vitro Screening

Chinchilli K., Singh P., Swain B., Goud N., Sigalapalli D., Choli A., Angeli A., Nanduri S., Yaddanapudi V., Supuran C., Arifuddin M.

(Eng)

Vol 24, No 14 (2024)

Antidepressant Sertraline Hydrochloride Inhibits the Growth of HER2+ AU565 Breast Cancer Cell Line through Induction of Apoptosis and Cell Cycle Arrest

Fayyaz S., Atia-Tul-Wahab , Irshad R., Siddiqui R., Choudhary M.

(Eng)

Vol 16, No 12 (2016)

Mutant B-Raf Kinase Inhibitors as Anticancer Agents

Asati V., Bharti S., Mahapatra D.

(Eng)

Vol 14, No 5 (2014)

Steroidal Cardiac Na+/K+ ATPase Inhibitors Exhibit Strong Anti-Cancer Potential in vitro and in Prostate and Lung Cancer Xenografts in vivo

Dimas K., Papadopoulou N., Baskakis C., Prousis K., Tsakos M., Alkahtani S., Honisch S., Lang F., Calogeropoulou T., Alevizopoulos K., Stournaras C.

(Eng)

Vol 13, No 3 (2013)

Histone Deacetylase Inhibitors as Potential Therapeutic Agents for the Treatment of Malignant Mesothelioma

Katafygiotis P., Giaginis C., Patsouris E., Theocharis S.

(Eng)

Vol 12, No 1 (2012)

New Targeted Therapies for Anaplastic Thyroid Cancer

Antonelli A., Fallahi P., Ulisse S., Martina Ferrari S., Minuto M., Saraceno G., Santini F., Mazzi V., D'Armiento M., Miccoli P.

(Eng)

Vol 11, No 1 (2011)

Dual-Specificity MAP Kinase Phosphatases as Targets of Cancer Treatment

Nunes-Xavier C., Roma-Mateo C., Rios P., Tarrega C., Cejudo-Marin R., Tabernero L., Pulido R.

(Eng)

Vol 25, No 7 (2025)

Emerging AXL Inhibitors in Oncology: Chemical and Biological Advances in Targeted Cancer Therapy

Shah K., Gopal K., Kumar S., Saha S.

(Eng)

Vol 13, No 2 (2013)

Synthesis and Biological Evaluation of Novel Antifolate Analogs as Potential Anticancer Treatment

F. Stoicescu D., Rotaru M.

(Eng)

Vol 16, No 11 (2016)

Docking Studies of Glutamine Valproic Acid Derivative (S)-5- amino-2-(heptan-4-ylamino)-5-oxopentanoic Acid (Gln-VPA) on HDAC8 with Biological Evaluation in HeLa Cells

Martínez-Ramos F., Luna-Palencia G., Vásquez-Moctezuma I., Méndez-Luna D., Fragoso-Vázquez M., Trujillo-Ferrara J., Meraz-Ríos M., Mendieta-Wejebe J., Correa-Basurto J.

(Eng)

Vol 15, No 4 (2015)

Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance

Li S., Zhang W., Yin X., Xing S., Xie H., Cao Z., Zhao B.

(Eng)

Vol 13, No 10 (2013)

Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies

Qazi A., Hussain A., Hamid A., Qurishi Y., Majeed R., Ahmad M., Najar R., Bhat J., Singh S., Zargar M., Ali S., Saxena A.

(Eng)

Vol 12, No 6 (2012)

Neutrophil Elastase as a Target in Lung Cancer

Moroy G., J.P. Alix A., Sapi J., Hornebeck W., Bourguet E.

(Eng)

Vol 12, No 1 (2012)

Impact of Oncogenic Protein Tyrosine Phosphatases in Cancer

Hardy S., G. Julien S., L. Tremblay M.

(Eng)

Vol 25, No 3 (2025)

Pioneering the Battle Against Breast Cancer: The Promise of New Bcl-2 Family

Boroujeni A., Ates-Alagoz Z.

(Eng)

Vol 14, No 1 (2014)

Genetics, Structure, Function, Mode of Actions and Role in Cancer Development of CYP17

Sushko T., Gilep A., Usanov S.

(Eng)

1 - 72 of 72 Items

Search tips:

Search terms are case-insensitive
Common words are ignored
By default only articles containing all terms in the query are returned (i.e., AND is implied)
Combine multiple words with OR to find articles containing either term; e.g., education OR research
Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Username
Password
Remember me

Forgot password?	Register

Username
Password
Remember me

Forgot password?	Register

Search

Advanced filters

Search categories

Publication Date

Index terms

Search tips: